other studies have been published in the same time frame which increase the still meager data base.36
The purpose of this contribution is to summarize as concisely as possible the evolution of experience, since 1968, in the development of guidelines for genetic and environmental counseling in congenital heart diseases. A more detailed presentaion of various aspects of this material will be found elsewhere. 6 Genetics In table I we show the etiologic categories and approximate distribution of the congenital heart patients we are currently seeing in our clinic. About 8% of our patients may best be explained as having a primarily genetic basis for their heart defects. Almost all of this group have congenital heart disease in association with a syndrome, either chromosomal or Mendelian.
The familial recurrence of chromosomal syndromes is small, but the counseling must be based on the karyotype of the patient -and when indicated, on chromosomal evaluation of the parents. The possibility that minor chromosomal errors, detectable only by banding techniques, can produce congenital cardiovascular disease is under investigation. Amniocentesis may be required in future pregnancies to enable the physician to offer specific risk counseling. An exposition of chromosomal syndromes and congenital heart defects exceeds the scope of this review. However, relevant information, which has been collated recently, is summarized in table 2.
Mendelian disorders still appear to account for a very small, but very important, subset of congenital cardiovascular disease. What we have emphasized over the years is that a congenital heart lesion produced by a single mutant gene is usually part of a syndrome or anomalad of multiple phenotypic features -the results of the action of a single gene of large effect. We continue to emphasize this point, but recognize increasing possibilities for exceptions. This will be expanded in the discussion of Morton's model of multifactorial inheritance. The importance of single gene etiology is the high recurrence risk that accompanies this mode. The child with pulmonary stenosis (PS) who has a somewhat unusual facies should not be cavalierly dismissed as "just looking like his mother" and the family given a low recurrence risk -if the child (and mother) have Noonan syndrome. The recurrence risk of this syndrome is 50%, because it is autosomal dominant;7 and the recurrence risk of some form of congenital heart disease is 25%, because half of individuals with this syndrome are so affected. 8 What must be stressed now is the need for vigilance in recognizing Mendelian disorders, so that the counseling offered is specific and appropriate. Tables 3, 4 and 5 summarize selected congenital and abiotrophic cardiovascular anomalies produced by single mutant genes -usually as part of a syndrome. Table 6 lists syndromes of uncertain etiology in which cardiovascular disease is important.
The great majority of patients with congenital heart disease are still best explained by multifactorial inheritance (i.e., there is a genetic predisposition interacting with an environmental trigger to produce cardiovascular maldevelopment). The genetic predisposition is usually presumed to be polygenic -the small, additive effects of many genes. However, a single locus or a small number of loci may be proposed to interact with environmental influences.
Three models of multifactorial inheritance are commonly 205 In whichever model is used, the more affected first-degree relatives there are, the greater is the risk for recurrence within the family (increased liability). The recurrence risk is also somewhat higher if the affected first-degree relative is a parent rather than a sib. In congenital heart disease, if there are two affected first-degree relatives the recurrence risk for the next child becomes two to three times as great as compared to one affected first-degree relative. In conditions of high heritability, if the two affected first-degree relatives are parent and child, the recurrence risk is higher than for two affected sibs. If there are three or more affected first-degree relatives, the recurrence risk increases greatly. We have called such families type C families (see fig. 1 ), and counsel that the recurrence risk is likely to be what has already been experienced in the family. The unusual pedigree of ventric- figure 2 illustrates the point. Yet to counsel a very high recurrence risk in the absence of affected parents is not consistent with the usual expectation in multifactorial inheritance.
However, there are possible explanations for this type C family within the various models of multifactorial inheritance. They require some knowledge of the natural history of VSD. In the range of 30-70% of ventricular septal defects close spontaneously. The presumably unaffected mother of the proband in figure 2 had a heart murmur in infancy that went away. It is also possible that the father of the proband had a VSD that was not recognized before it closed spontaneously in infancy. In Falconer's and Edwards' models the possibility of being affected increases abruptly or smoothly as the liability increases. This family could represent an extreme example within the context of a continuous distribution. In Morton's model one could invoke the possibility of a rare mutant gene. We would feel more com- An observation that is supported by our data,2 but not by Anderson's findings,5 is that the more common the defect is in the general population, the more likely it is to recur in first-degree relatives. This is consistent with expectation in multifactorial inheritance and is compatible with combined data derived from several series including our own and that of Anderson.
A difficult question that arises in the analysis of families is: what is the underlying mechanism of maldevelopment in a given family? If ventricular septal defect appears to be the anomaly running in the family, is the recurrence risk of 3% the risk for ventricular septal defect alone? Must the population risks for other congenital heart diseases, such as atrial septal defect and patent ductus arteriosus be added to the empiric risk figure? If the assumption of multifactorial inheritance is correct for a given family, then one must also assume an interaction between a genetic predisposition (usually the products of many genes, but perhaps as few as one gene) and an environmental trigger (e.g., drug, virus, maternal nutrition or metabolism, fetal hemodynamics). If One cannot be sure in a single case what the core lesion "running in the family" really is. The first child may have VSD and the second tetralogy of Fallot. We would counsel that the core lesion in the family is the more serious defect, tetralogy of Fallot, and that the recurrence risk is the empiric risk, the recurrence of any congenital heart defect starting with a proband with tetralogy. We would in this family regard VSD as aformefruste of the tetralogy. What parents want to know is what is the chance that their next child will have a congenital heart lesion. We do not believe that every individual is predisposed to every possible birth defect and every possible congenital heart lesion. So we do not feel that it is necessary to add to the equation of risk for a specific heart defect the theoretic risks for all other cardiovascular anomalies.
We assume that the heart lesions in the first-degree relatives are more likely to be related to the same developmental abnormalities rather than to different ones. Clusters of similar anomalies in families appear to support this. A familial recurrence of a heart lesion that apparently bears no developmental relationship to a previously encountered defect may indeed be unrelated (or may be a manifestation of a common mechanism of maldevelopment which is obscure to the observer).
As Although it is necessary for epidemiologists to debate whether it is anticonvulsants or epilepsy itself that is teratogenic,'5 the clinician is able to distinguish differences in the pattern of anomalies for trimethadione and hydantoin.
The alert practitioner has been, and will continue to be, the major resource in the recognition of teratogens.
The Genetic-Environmental Interaction in
Various Cardiovascular Anomalies In comparing recurrence risks found in different series in the world literature, there are striking similarities and some equally striking dissimilarities. This is unavoidable because no single series has enough cases to overcome the biases introduced by outlying observations. Tables 9 and 10 summarize our experience, and in the last columns give combined, empiric recurrence risks derived from data from several investigative groups.2-' 18226 A finding in these tables that only became apparent to us during the preparation of this review is that the risk is generally higher for the offspring than for the sib of an affected individual. This difference is compatible with the predictions of Smith"7 for conditions of high heritability.
The selection of cases varies. Fuhrmann's' 1,19 cases are restricted to recurrence of the same or a "related" abnormality, and presumably exclude patients who have cardiovascular anomalies as part of a syndrome, even if the syndrome is of unknown etiology. Anderson5 admits patients who do not have concordant cardiovascular anomalies, but eliminates patients having syndromes of known and unknown etiology. He also eliminates teratogenic exposures which may play a modest to an important role in the geneticenvironmental interaction. Zetterqvist4 reports familial recurrence of concordant and discordant lesions, but emphasizes that it is the concordant lesions that are of genetic interest -presumably on the assumption that socalled discordant lesions are unlikely to be developmentally related.
We report familial recurrence of congenital cardiovascular disease whether the lesions are concordant or are apparently discordant. We do this because we feel that the basic mechanisms of maldevelopment are not, as yet, clearly defined -and that the meaningful figure in counseling is the recurrence of congenital cardiovascular disease, not the recurrence of a specific defect. In the past, we eliminated chromosomal and single gene etiologies and rubella. As we collect new data we eliminate the high risk teratogens shown in table 7. However, the recurrence risk in our own cumulative series, starting in 1962 (tables 9 and 10), would not completely reflect these recent changes.
Analysis of concordant and discordant anomalies is highly informative.27 It may eventually prove more instructive to group by pathogenesis (e.g., abnormalities of truncoconal septation or endocardial cushion formation) rather than by pathologic diagnosis (e.g., tetralogy of Fallot.) We would then have to revise our theoretic recurrence risks which are based on traditional diagnoses, imprecise formulas and uncertain population frequencies. We counsel the recurrence risk figure for a specific teratogen if it is higher than the empiric recurrence risk figure for a specific lesion. For example, we give the higher recurrence risk for cardiovascular disease in the next infant of a diabetic mother (5%)28 than the lower recurrence risk for the lesion itself (e.g., 2% for coarctation of the aorta). Obviously if the teratogen can be avoided -such as amphetaminescounseling would be to protect the next pregnancy from the agent in question. For our empiric risk records we do not eliminate recurrences associated with syndromes of unknown etiology or potential teratogens which are not reasonably well established as high risk. Eventually as more teratogens are identified, the recurrences attributable to these agents may bring the non-teratogen related recurrences to a much lower level. In our counseling, we constantly emphasize the need to avoid unnecessary exposures to drugs and other potential environmental hazards in the pregnancies that will follow the delivery of an infant with congenital cardiovascular disease.
It will be observed that, as increasing numbers of cases are published, it is both reasonable and necessary to combine data to smooth out the discrepancies produced by outlying observations in individual series. It is somewhat painful for us to modify counseling figures we have used over the years, which have been derived exclusively from our own data. But this is all related to increasing knowledge of the subject, so the risk figures we use are those in the last columns of tables 9 and 10 -consensus figures derived from several series. It is likely that high risk families having single gene etiologies have previously been mixed in with the presumed multifactorial inheritance subjects (e.g., dominant atrial septal defect and dominant pulmonary stenosis in Noonan syn- Left axis in family members may be forme fruste of more complete disease.
Recurrence in sibs exceeds expectation for multifactorial inheritance.
Increasing parity and/or maternal infection may play etiologic role via anti-heart antibody.
Heart lesions in sibs have not been concordant with tricuspid atresia and do not exceed expectation for general population. Low recurrence risk. Lithium a specific teratogen. Low recurrence risk. Trunco-conal anomalies predominate. Low recurrence risk does not exceed expectation for general population.
No concordant recurrence (but pulmonary stenosis reported in sib).
Recurrence rate for all congenital heart lesions in sibs exceeds population expectation. However, only 25% of recurrences are hypoplastic left heart. drome). Since such cases are not now included in the data base of empiric recurrence risks, the recently tabulated risks are frequently lower than those recorded a decade ago. The value of empiric recurrence risk data is diminishing as the trend is toward greater specificity in etiologic understanding and in genetic and environmental counseling. Table 11 provides some points of interest regarding etiology and counseling in selected cardiovascular anomalies and accentuates the recurring theme of specificity. It is essential to obtain a pedigree and look for single gene and chromosomal factors as well as potential teratogens before committing oneself to any position on cause or possible recurrence risks. The practicing pediatrician or cardiologist is in an excellent position to answer the questions of the patient and family. However, if there is not sufficient interest or motivation in this area, it would be wise to enlist the aid of a clinical geneticist. A background of information is provided in this article and is expanded elsewhere.6 Four brief illustrations follow.
In the Falconer and Edwards models, the entire basis for recurrence risk in multifactorial inheritance is the relationship of the normal distribution curve of predisposition and the threshold. The curve moves to the right and the threshold to the left with increasing liability to a disease. In some unusual type C families ( fig. 1 ) liability may occupy a large area under the curve rather than a small portion of the tail. There is a theoretic possibility that these risks can exceed those in Mendelian inheritance. In figure 1 , we have also added our interpretation of how Morton's model might apply to etiologic concepts in congenital heart diseases. The blackened areas of bimodality represent rare mutant genes. Using what we know of the natural history of VSD, the mother of the proband in figure 2 most likely had a spontaneously closing VSD. While the models are of interest to geneticists, what is essential for the physician in dealing with the family is to recognize the high risk. After the birth of the first affected child in the sibship of the proband, a careful history of the family, including the presence of the disappearing murmur in the mother, should point to the possibility of unusual risk. After the birth of the second child, this family would be identified as type C (three affected first-degree relatives on the strong likelihood that the mother had a defect). Our counseling in such a family is that they may expect a risk, in subsequent pregnancies, comparable to what has already been experienced.
The family in figure 3 has direct transmission and too many individuals with ASD to permit us to offer an initial low risk. Even in the absence of stigmata of a single gene syndrome, such as that of Holt-Oram, we would counsel high-risk, dominant inheritance. A mother who must continue to take lithium to function outside of an institution cannot be told that Ebstein anomaly almost never recurs. There is a 10% risk of congenital heart disease, most often Ebstein anomaly, following maternal exposure to lithium.
The child with pulmonary stenosis and a few stigmata of Noonan syndrome, whose mother also has some subtle features of the syndrome, represents a different problem in counseling than the child who has no stigmata. The difference is simply that one is dealing with high-risk, dominant inheritance not low-risk, multifactorial inheritance.
The preceding are typical examples of specificity counseling. Our present position is that empiric and theoretic recurrence risks have their place as general and rather imprecise guidelines. The responsibility of the counselor is to probe carefully for causes which are as specifically defined as the state of the art permits. This then becomes the basis not only for knowledgeable counseling, but for the development of programs of prevention.
Conclusion
The approach to genetic and environmental counseling in congenital heart disease has evolved during the past decade in the direction of greater specificity. At present, it appears that about 8% of cases are predominantly genetic and about 2% are predominantly environmental in etiology. In the remaining 90% there is an important genetic-environmental interaction. Within this latter group (multifactorial inheritance) it should be possible to segregate and identify further etiologic subsets of predominantly environmental or predominantly genetic influences. It is imperative that highrisk patients in any etiologic mode be recognized as such. General guidelines which have emerged regarding low-risk (type B)2 patients in the mode of multifactorial inheritance include: a higher risk for offspring than for sibs of a patient with congenital heart disease; a higher risk if the lesion is common (e.g., ventricular septal defect) than if the lesion is uncommon (e.g., tricuspid atresia); a two-fold to three-fold increase in risk if there are two affected first-degree relatives rather than one. A risk comparable to or greater than Mendelian risks is found if there are three affected firstdegree relatives (especially if there is an affected parent). This is the so-called type C family.2 Answers to patients' questions regarding etiology and recurrence risks should be made in the context of carefully evaluated clinical and historical data looking specifically for Mendelian, chromosomal and multifactorial inheritance modes and environmental effects.
teratrial conduction time at 92 msec (control of 44 msec, P < 0.001) and the mean P wave duration at 132 msec (control of 112 msec, P < 0.01). The flutter group also demonstrated a higher incidence of sinus node dysfunction and ventricular conduction disease compared to the control group. These data indicate that patients who develop atrial flutter have atrial conduction disease. Atrial conduction disease appears to be 1) a major predisposing factor for the development of atrial flutter and 2) a part of the fibro-degenerative conduction disease spectrum.
cidence of atrial flutter,' atrial enlargement itself is not the only predisposing factor in this patient population.2 Patients without detectable atrial enlargement or other contributory factors (metabolic, bronchopulmonary disease, etc.) also develop atrial flutter. This study was designed to compare atrial conduction of atrial flutter patients without atrial enlargement to a normal group, in order to determine if atrial conduction abnormalities are a major predisposing factor in the development of atrial flutter.
Materials and Methods

Subjects
The atrial flutter group consisted of 21 patients who had documented spontaneous atrial flutter. The dysrhythmia
